Daré Bioscience receives $851,796 in additional contraceptive research grant funding
DARE•Daré Bioscience received $851,796 under an existing grant agreement worth up to approximately $10.7 million to support development of a non-hormonal intravaginal contraceptive for women in low- and middle-income countries.




